US Patent Issued to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services on July 7 for "Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,204, issued on July 7, was assigned to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)" was invented by Kapil Bharti (Potomac, Md.), Janine Davis (Baltimore), Arvydas Maminishkis (Washington) and Sheldon S. Miller (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "High efficiency methods for producing retinal pigment epithelial cells from induced pluripotent stem cells (iPSCs) are disclosed herein. The iPSCs are produced from somatic cells, including retinal pigmen...